30.01.2015 RHÖN-KLINIKUM AG  DE0007042301

DGAP-News: RHÖN-KLINIKUM AG Strengthens its Competitive Position and Invests 4 Million Euros in Research into Cutting-Edge Medical Care and Treatment Excellence in 2015


 
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Strategic Company Decision/Miscellaneous RHÖN-KLINIKUM AG Strengthens its Competitive Position and Invests 4 Million Euros in Research into Cutting-Edge Medical Care and Treatment Excellence in 2015 30.01.2015 / 13:29 --------------------------------------------------------------------- CORPORATE NEWS RHÖN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt / Saale www.rhoen-klinikum-ag.com RHÖN-KLINIKUM AG Strengthens its Competitive Position and Invests 4 Million Euros in Research into Cutting-Edge Medical Care and Treatment Excellence in 2015 Bad Neustadt / Saale, 30th January 2015 With a significant increase in the research budget for 2015 RHÖN-KLINIKUM AG is consciously strengthening its competitive position in treatment innovation and state-of-the-art healthcare. Accordingly projects concentrating on "research and innovation" and "treatment excellence and network medicine" are to be financed in the coming months with a total volume of roughly 4 million Euros. The research and innovation package includes projects for all five corporate group sites. "Our hospitals offer state-of-the-art healthcare which is orientated to maximum medical care and has a direct link to research. The use of advanced medical technology based on the latest results of research being efficiently transferred to medical practitioners is essential here as is effective nursing care for our patients," said Dr. Dr. Martin Siebert, CEO of RHÖN-KLINIKUM AG. "It is therefore self-explanatory that we are making significant investments in this area in order to maintain and expand our attractive range of services and retain our unique standing in the market. We hope to obtain further competitive advantages from this research expenditure in the medium to long term and therefore also clearly achieve benefits in revenues and growth," Siebert continued. The company is financing a total of 61 individual projects this year. Particular focus will be placed on personalised medical care with tailor-made therapeutic methods using state-of-the-art molecular genetics. A specific application is the exact circumstances and treatment of brain tumours, for example. Projects on telemedical healthcare and e-health are another particular emphasis. In future, implanted devices, such as pace-makers or defibrillators, will send data on complications or particular occurrences to special centres on a continuous basis. Doctors will then be able to treat the patients accordingly before serious complications arise. There will also be projects on organization and logistics such as improving the link between in-patient treatment and follow-up care in the home. ************************************************************************** RHÖN-KLINIKUM AG AG is one of the largest healthcare providers in Germany. With ten hospitals in five locations and a total of 5,300 beds we offer affordable cutting-edge medical care with a direct link to universities and research institutes. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt (Oder) and Giessen and Marburg. A total of approx. 15,000 employees work for RHÖN-KLINIKUM AG. Further information is available at: www.rhoen-klinikum-ag.com Your Contact Persons: RHÖN-KLINIKUM AG Achim Struchholz Group Division Head of Corporate Communication Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telephone: + 49 - 9771 65-1327 Facsimile: + 49 - 9771 65-1820 E-Mail: [email protected] Dr. Kai G. Klinger Head of Investor Relations Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telephone: + 49 - 9771 65-1318 Facsimile: + 49 - 9771 99-1736 E-Mail: [email protected] --------------------------------------------------------------------- 30.01.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 317951 30.01.2015


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.463,98
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 105,88
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 40,40
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,76
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 40,17
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,74
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 109,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,58
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 12,900 Halten 863,82
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
21,50 28,52 0,70 22,22
KBV KCV KUV EV/EBITDA
0,69 7,92 0,59 7,57
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,00 0,00 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
17,80% 14,97% 29,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK